findmyKOL
Clinical trialNCT01155817CompletedPhase 1Interventional

Phase 1 Nilotinib in Steroid Dependent/Refractory Chronic Graft Versus Host Disease

SponsorStanford UniversityEnrollment33Bone Marrow Transplant FailureLymphoma, Non-HodgkinLymphoma, T-Cell, Peripheral
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

PRIMARY OBJECTIVES: Determine the safety and tolerability of nilotinib in steroid dependent / refractory cGVHD. SECONDARY OBJECTIVES: Determine the clinical efficacy of nilotinib in steroid dependent / refractory cGVHD.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Gordon and Leslie Diamond Health Care Centre Hematology Administration

    Vancouver, British Columbia, Canada

United States
  • Stanford University School of Medicine

    Stanford, California, United States

  • Colorado Blood Cancer Institute

    Denver, Colorado, United States

  • Roswell Park Cancer Institute

    Buffalo, New York, United States

  • Fred Hutchinson Cancer Research Center

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Nilotinib →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Aug 2010
Primary completion
31 Dec 2013
Completion
31 Dec 2013
Last update posted
15 Apr 2020
Registered enrollment
33
Registry id
NCT01155817
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.